Laura Gemmo

Laura Gemmo

Auto-generated profile, based on publicly available information

Laura Gemmo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Redox Experimental Medicine
Verified
Journal Article
Open access
MAMalak Alghamdi
Malak Alghamdi
LGLaura Gemmo
Laura Gemmo
AGAnna Guiotto
Anna Guiotto
APAlessandra Pecorelli
Alessandra Pecorelli
Giuseppe ValacchiGiuseppe Valacchi
Giuseppe Valacchi
Graphical The interplay between oxidative stress and inflammation, often referred to as OxInflammation, represents a central pathological mechanism in many neurological disorders. Within the central nervous system, this interplay involves a feedforward loop between redox imbalance and innate immune activation, forms a self-perpetuating cycle that disrupts mitochondrial homeostasis, amplifies glial reactivity, and exacerbates neuronal damage. Among redox-sensitive regulators, forkhead box O (FOXO) transcription factors have emerged as key modulators of cellular adaptation to oxidative and inflammatory stress. FOXOs integrate metabolic growth factors and stress-activated signaling pathways to promote transcriptional programs controlling antioxidant defense, autophagy, apoptosis, and immune responses depending on the context and on the activators. FOXO3a activity is tightly controlled by post-translational modifications and cofactor interactions, which determine its nuclear–cytoplasmic localization and target gene selectivity. Over time, this OxInflammatory milieu leads to progressive neuroinflammation, synaptic dysfunction, neuronal death, and impaired repair mechanisms, underlying the pathogenesis of neurodegenerative disorders, such as Alzheimer’s disease (AD), multiple sclerosis (MS), autism spectrum disorder (ASD), and Rett syndrome (RTT). Increasing evidence implicates aberrant FOXO3a regulation in both neurodegenerative and neurodevelopmental disorders, positioning it as a molecular nexus linking oxidative stress to inflammatory pathology. This review highlights how FOXO3a serves as a central switch in redox and inflammatory signaling during neurological diseases and highlights its therapeutic potential as a molecular target to restore homeostasis in oxidative–inflammatory states, particularly in AD, MS, ASD, and RTT.